Myelomonoblastic leukaemia cells carrying the PEBP2β/MYH11 fusion gene are CD34+, c‐KIT+ immature cells

To clarify the aspects affected by the PEBP2β/MYH11 fusion gene involved in the inv(16), we analysed immunophenotypes in myelomonoblastic leukaemias. We found high expressions of CD34 and c‐KIT antigens in myelomonoblastic cells from all patients carrying this fusion gene, including two with M4 and one CML blastic phase, in contrast to those with M4 without the fusion gene. These findings indicate that immunophenotyping is useful for detecting a leukaemia with the fusion gene in myelomonoblastic leukaemias and that the PEBP2β/MYH11 gene is involved in immature cells expressing CD34 and c‐KIT antigens.

• Publication year

  1997

• Venue

  British Journal of Haematology

• Publication date

  1997-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1365-2141.1997.1012917.xPMID 9207416
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of the chromosome 16 CBF beta-MYH11 fusion transcript in myelomonocytic leukemias.

  1995cited by this paper
• Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia.

  1995influential reference
• Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia.

  1993cited by this paper
• Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor

  1993cited by this paper
• Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression.

  1993cited by this paper
• Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha.

  1993cited by this paper
• Human smooth muscle myosin heavy chain gene mapped to chromosomal region 16q12.

  1993cited by this paper
• Acute unclassified leukemia originating from undifferentiated cells with the aberrant rearrangement and expression of immunoglobulin and T-cell receptor genes.

  1991cited by this paper
• Prognostic value of lymphocyte surface markers in acute myeloid leukemia.

  1991cited by this paper
• Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.

  1991cited by this paper

• leukemogenesis in mice for CBFB-MYH11 with D816 mutations cooperates with KIT

  2014cites this paper
• implications for mechanisms of pathogenesis familial platelet disorder with predisposition to acute myelogenous leukemia: In vitro analyses of known and novel RUNX1/AML1 mutations in dominant

  2013cites this paper
• Cytarabine Induction Followed by Imatinib Post-Induction Therapy in Patients with Acute Myeloid Leukaemia - Limited Effects in a Case Series

  2013cites this paper
• KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in mice.

  2012cites this paper
• KIT with D 816 mutations cooperates with CBFB-MYH 11 for leukemogenesis in mice

  2012cites this paper
• Acute Leukaemia: Integration of Morphological, Immunophenotypic and Genetic Information and the WHO Classification

  2010cites this paper
• myeloid leukemia chimeric gene in t(8;21)(q24;q22) acute AML1-TRPS1 factors by the Concurrent transcriptional deregulation of AML1/RUNX1 and GATA

  2008cites this paper
• Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemia.

  2007cites this paper
• Common gene expression signatures in t(8;21)‐ and inv(16)‐acute myeloid leukaemia

  2006cites this paper
• The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia

  2005cites this paper
• Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients.

  2005cites this paper
• p15 mRNA expression detected by real-time quantitative reverse transcriptase-polymerase chain reaction correlates with the methylation density of the gene in adult acute leukemia.

  2005cites this paper
• Imatinib mesylate (STI571) for myeloid malignancies other than CML.

  2004cites this paper
• Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype

  2003cites this paper
• The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications.

  2003cites this paper
• Amplification of a novel c-Kit activating mutation Asn(822)-Lys in the Kasumi-1 cell line: a t(8;21)-Kit mutant model for acute myeloid leukemia.

  2002cites this paper
• Stem Cell Factor

  2002cites this paper
• The absence of the p15INK4B gene alterations in adult patients with precursor B‐cell acute lymphoblastic leukaemia is a favourable prognostic factor

  2002cites this paper
• In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis.

  2002cites this paper
• C-kit mutations in core binding factor leukemias.

  2000cites this paper
• Enhanced myeloid specificity of CD117 compared with CD13 and CD33.

  1999cites this paper
• Diagnosis of childhood acute myeloid leukemia.

  1999cites this paper
• Acute myelomonoblastic leukemia carrying the PEBP2beta/MYH11 fusion gene.

  1998cites this paper